The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression

Xiaolei Wei, Meng Xu, Yongqiang Wei, Fen Huang, Tong Zhao, Xiangzhao Li, Ru Feng, B. Hilda Ye

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression'. Together they form a unique fingerprint.

Medicine & Life Sciences